Physician profile
Richard Teames
NPI 1255686143
$745,638.63
in general payments reported to CMS, 2019-2025
9 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $92K · 2021: $72K · 2022: $148K · 2023: $117K · 2024: $100K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $167K · Honoraria: $97K · Travel and Lodging: $43K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $4,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $167,200.00 |
| Honoraria | $96,965.00 |
| Travel and Lodging | $43,447.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,839.93 |
| Food and Beverage | $4,532.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $669,458.31 | 2019-2025 | Exparel, Iovera, Zilretta |
| Mindray Ds USA, INC. | $34,620.41 | 2021-2025 | A5 Anesthesia System, Te X, Te7 Max |
| Avanos Medical | $27,978.94 | 2019-2022 | |
| Fujifilm Sonosite, INC. | $13,182.08 | 2019-2022 | |
| Pajunk Medical Systems, Lp | $190.81 | 2019 | |
| Merck Sharp & Dohme LLC | $72.64 | 2019-2020 | |
| Edwards Lifesciences Corporation | $68.16 | 2020-2021 | |
| Karl Storz Endoscopy-America | $39.63 | 2019 | |
| Eagle Pharmaceuticals, INC. | $27.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Teames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.